won a lawsuit against the life sciences company Lonza for infringing patents on some of its nutritional products.
A jury in the U.S. District Court in Wilmington, Del., found that Lonza willfully infringed the company's patents, which were deemed valid in court.
"The verdict further demonstrates both the company's resolve to vigorously defend our intellectual property portfolio and the strength of Martek's patent portfolio in the U.S. marketplace," said CEO Steve Dubin.
The company intends to ask the court for a permanent injunction. However, the decision could be appealed by Lonza to the U.S. Court of Appeals for the Federal Circuit.